RA Capital Healthcare Fund LP, Director at Artiva Biotherapeutics, bought ARTV on Jun 12, 2026
Data as of Oct 16
▲ BUY$3.4M391,019 shares at $8.57RA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.
- Traded
- Jun 12, 2026
- Disclosed
- Jun 16, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ARTV since disclosure
−34.3%
Similar stocks (XLV) since disclosure
+15.5%
XLV — its sector index fund
Change in closing price from Jun 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$1.1Mdisclosed Jun 16 · filed the same day
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$139Kdisclosed Jun 16 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$3.4Mdisclosed Jun 16 · filed 4 days after the trade